These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34261897)

  • 41. [Hepatobiliary Manifestation of Inflammatory Bowel Disease].
    Seo KI; Kang SB
    Korean J Gastroenterol; 2019 May; 73(5):248-259. PubMed ID: 31132831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Research advances of autoimmune liver diseases in 2018].
    Chen Y; Wang QX; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):14-17. PubMed ID: 30685918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characteristics and outcome of autoimmune liver disease in Asian children.
    Lee WS; Lum SH; Lim CB; Chong SY; Khoh KM; Ng RT; Teo KM; Boey CC; Pailoor J
    Hepatol Int; 2015 Apr; 9(2):292-302. PubMed ID: 25788179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Post-Transplant Management and Complications of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Primary Sclerosing Cholangitis including Disease Recurrence.
    Henson JB; King LY
    Clin Liver Dis; 2024 Feb; 28(1):193-207. PubMed ID: 37945160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evolving Practice and Changing Phenotype in Pediatric Autoimmune Liver Disease: Outcomes From an Australian Center.
    Singh H; Balouch F; Noble C; Lewindon P
    J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):80-85. PubMed ID: 29470284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.
    Navaneethan U; Shen B
    Inflamm Bowel Dis; 2010 Sep; 16(9):1598-619. PubMed ID: 20198712
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extrahepatic autoimmunity in autoimmune liver disease.
    Floreani A; De Martin S; Secchi MF; Cazzagon N
    Eur J Intern Med; 2019 Jan; 59():1-7. PubMed ID: 30360943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The challenges of liver transplantation in children with primary sclerosing cholangitis.
    Venkat VL; Ranganathan S; Sindhi R
    Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):289-94. PubMed ID: 25592492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoimmune liver diseases and diabetes.
    Jensen AH; Ytting H; Winther-Sørensen M; Burisch J; Bergquist A; Gluud LL; Wewer Albrechtsen NJ
    Eur J Gastroenterol Hepatol; 2023 Sep; 35(9):938-947. PubMed ID: 37505973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The management of autoimmunity in patients with cholestatic liver diseases.
    Ali AH; Carey EJ; Lindor KD
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):73-91. PubMed ID: 26523975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of paediatric onset primary sclerosing cholangitis on clinical course and outcome of inflammatory bowel disease: a case-control population-based study in Finland.
    Tenca A; Jaakkola T; Färkkilä M; Arola J; Kolho KL
    Scand J Gastroenterol; 2019 Aug; 54(8):984-990. PubMed ID: 31402720
    [No Abstract]   [Full Text] [Related]  

  • 52. Liver abnormalities in bowel diseases.
    Kummen M; Schrumpf E; Boberg KM
    Best Pract Res Clin Gastroenterol; 2013 Aug; 27(4):531-42. PubMed ID: 24090940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Appearance of hepatobiliary diseases in a population-based cohort with inflammatory bowel diseases (Inflammatory Bowel Disease Cohort of the Uppsala Region).
    Rönnblom A; Holmström T; Tanghöj H; Rorsman F; Sjöberg D
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1288-92. PubMed ID: 25777994
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoimmune sclerosing cholangitis: Evidence and open questions.
    Terziroli Beretta-Piccoli B; Vergani D; Mieli-Vergani G
    J Autoimmun; 2018 Dec; 95():15-25. PubMed ID: 30366655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ABC of diseases of liver, pancreas, and biliary system. Other causes of parenchymal liver disease.
    Ryder SD; Beckingham IJ
    BMJ; 2001 Feb; 322(7281):290-2. PubMed ID: 11157536
    [No Abstract]   [Full Text] [Related]  

  • 56. Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?
    Nakazawa T; Naitoh I; Hayashi K; Sano H; Miyabe K; Shimizu S; Joh T
    World J Gastroenterol; 2014 Mar; 20(12):3245-54. PubMed ID: 24696608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases.
    Claise C; Johanet C; Bouhnik Y; Kapel N; Homberg JC; Poupon R
    Liver; 1996 Feb; 16(1):28-34. PubMed ID: 8868075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients.
    Silva J; Brito BS; Silva INN; Nóbrega VG; da Silva MCSM; Gomes HDN; Fortes FM; Pimentel AM; Mota J; Almeida N; Surlo VC; Lyra A; Rocha R; Santana GO
    Biomed Res Int; 2019; 2019():7604939. PubMed ID: 30834274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Ulcerative colitis associated with autoimmune hepatitis: a differential form of inflammatory bowel disease?].
    Giraldo Escobar LM; Crespo Madrid N; Vila Miravet V; Pujol Muncunill G; Varea Calderón V; Martín de Carpi J
    An Pediatr (Barc); 2015 Jan; 82(1):e78-81. PubMed ID: 24360855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical course of inflammatory bowel disease and impact on liver disease outcomes in patients with autoimmune sclerosing cholangitis.
    Nayagam JS; Mandour MO; Taylor A; Heneghan MA; Dubois PC; Hayee B; Lee HM; Vadamalayan B; Samyn M; Joshi D; Kent AJ
    Clin Res Hepatol Gastroenterol; 2022; 46(7):101980. PubMed ID: 35728760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.